Skip to content

Effect of topical Zingiber cassumunar on painful diabetic neuropathy : A double-blind controlled trial

Effect of topical Zingiber cassumunar on painful diabetic neuropathy : A double-blind controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200221001
Enrollment
Unknown
Registered
2020-02-21
Start date
2019-02-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

&#45

Interventions

plai balm 15%w/w apply 3 times/day and received gabapentin 300 mg once a day before bedtime ,placebo balm apply 3 times/day and received gabapentin 300 mg once a day before bedtime
Active Comparator Drug,Placebo Comparator Drug
plai balm 15%w/w ,placebo balm

Sponsors

none
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Criteria included aged of 20-60 years who has been diagnosed with diabetic mellitus for 1 year at least, and had been tested for HbA1c within 6 months, patients who had suffered from pain intensity on scale as moderate (Numerical rating scale (NRS), Pain score ≥ 4), the defined positive monofilament score result.

Exclusion criteria

Exclusion criteria: Patient who has been diagnosed with diabetic mellitus less than one year, with other caused neuropathy, clinically significant cardiovascular, foot ulcer or/and infection, pregnancy and lactation, and allergic of Plai, were excluded.

Design outcomes

Primary

MeasureTime frame
the mean change of pain scores 2 weeks numerical rating scale

Secondary

MeasureTime frame
50% reduction of pain 4 weeks numerical rating scale

Countries

Thailand

Contacts

Public ContactNACHAPOL JATUTEN

selaphum hospital

jatuten.n@gmail.com0895779664

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026